Intracoronary Brachytherapy, a Promising Treatment Option for Diabetic Patients: Results from a European Multicenter Registry (RENO)

Catheterization and Cardiovascular Interventions

Volumn 61, Issue 2, 2004, Pages 173-178

  Naber, Christoph K ^a   Baumgart, Dietrich ^a   Bonan, Raoul ^b   Wegscheider, Karl ^c   Serruys, Patrick W ^d   Colombo, Antonio ^e   Silber, Sigmund ^f   Eeckhout, Eric ^g   Eggebrecht, Holger ^a   Erbel, Raumund ^a   Urban, Philip ^h  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF HAMBURG   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^f Cardiology Practice and Hospital   (Germany)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h LA TOUR HOSPITAL   (Switzerland)

Author keywords

Brachytherapy; Diabetics; In stent restenosis; Percutaneous transluminal coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; STRONTIUM 90; TICLOPIDINE;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; EXCIMER LASER; FEMALE; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; ROTATIONAL ATHERECTOMY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

BRACHYTHERAPY; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY RESTENOSIS; DIABETES COMPLICATIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; STATISTICS, NONPARAMETRIC; STENTS; TREATMENT OUTCOME;

EID: 10744233612     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10795     Document Type: Article

References (28)

1. Marso SP, Mak KH, Topol EJ. Diabetes mellitus: biological determinants of atherosclerosis and restenosis. Semin Interv Cardiol 1999;4:129-143.
2. Kornowski R, Lansky AJ. Current perspectives on interventional treatment strategies in diabetic patients with coronary artery disease. Catheter Cardiovasc Interv 2000;50:245-254.
3. Mercado N, Boersma E, Wijns W, Gersh BJ, Morillo CA, de Valk V, van Es GA, Grobbee DE, Serruys PW. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001;38:645-652.
4. Abizaid A, Kornowski R, Mintz GS, Hong MK, Abizaid AS, Mehran R, Pichard AD, Kent KM, Satler LF, Wu H, Popma JJ, Leon MB. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J Am Coll Cardiol 1998;32:584-589.
5. Huynh T, Eisenberg MJ, Deligonul U, Tsang J, Okrainec K, Schechter D, Lefkovits J, Mak KH, Brown DL, Brieger D. Coronary stenting in diabetic patients: results from the ROSETTA registry. Am Heart J 2001;142:960-964.
6. Lansky AJ, Roubin GS, O'Shaughnessy CD, Moore PB, Dean LS, Raizner AE, Safian RD, Zidar JP, Kerr JL, Popma JJ, Mehran R, Kuntz RE, Leon MB. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation 2000;102:1364-1368.
7. Koster R, Kahler J, Terres W, Reimers J, Baldus S, Hartig D, Berger J, Meinertz T, Hamm CW. Six-month clinical and angiographic outcome after successful excimer laser angioplasty for in-stent restenosis. J Am Coll Cardiol 2000;36:69-74.
8. Schofer J, Schluter M, Rau T, Hammer F, Haag N, Mathey DG. Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study. J Am Coll Cardiol 2000;35:1554-1559.
9. Wong SC, Baim DS, Schatz RA, Teirstein PS, King SB III, Curry RC Jr, Heuser RR, Ellis SG, Cleman MW, Overlie P. Immediate results and late outcomes after stent implantation in saphenous vein graft lesions: the multicenter U.S. Palmaz-Schatz stent experience. J Am Coll Cardiol 1995;26:704-712.
10. Moustapha A, Assali AR, Sdringola S, Vaughn WK, Fish RD, Rosales O, Schroth G, Krajcer Z, Smalling RW, Anderson HV. Percutaneous and surgical interventions for in-stent restenosis: long-term outcomes and effect of diabetes mellitus. J Am Coll Cardiol 2001;37:1877-1882.
11. Mehran R, Dangas G, Abizaid A, Lansky AJ, Mintz GS, Pichard AD, Satler LF, Kent KM, Waksman R, Stone GW, Leon MB. Treatment of focal in-stent restenosis with balloon angioplasty alone versus stenting: short- and long-term results. Am Heart J 2001;141:610-614.
12. Klugherz BD, Meneveau NF, Kolansky DM, Herrmann HC, Schiele F, Matthai WH Jr, Groh WC, Untereker WJ, Hirshfeld JW Jr, Bassand JP, Wilensky RL. Predictors of clinical outcome following percutaneous intervention for in-stent restenosis. Am J Cardiol 2000;85:1427-1431.
13. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999;1001872-1878.
14. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, Wong SC, Fish D, Ellis S, Holmes DR, Kerieakes D, Kuntz RE. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001;344:250-256.
15. Waksman R, Bhargava B, White L, Chan RC, Mehran R, Lansky AJ, Mintz GS, Satler LF, Pichard AD, Leon MB, Kent KK. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000;101:1895-1898.
16. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171.
17. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of instent restenosis: the INHIBIT randomised controlled trial. Lancet 2002;359:551-557.
18. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002;106:1090-1096.
19. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, Schatz RA, Guarneri EM, Steuterman S, Cloutier DA, Leon MB, Tripuraneni P. A subgroup analysis of the scripps coronary radiation to inhibit proliferation poststenting trial. Int J Radiat Oncol Biol Phys 1998;42:1097-1104.
20. Gruberg L, Waksman R, Ajani AE, Kim HS, White RL, Pinnow EE, Satler LF, Pichard AD, Kent KM, Lindsay J Jr. The effect of intracoronary radiation for the treatment of recurrent in-stent restenosis in patients with diabetes mellitus. J Am Coll Cardiol 2002;39:1930-1936.
21. Moses JW, Moussa I, Leon MB, Teirstein PS, Fish RD, Ellis SG, Nawas D, Kluck B, Giorgianni JA, Donohoe D, Kuntz RE. Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I randomized trial). Am J Cardiol 2002;90:243-247.
22. Urban P, Serruys P, Baumgart D, Colombo A, Silber S, Eeckhout E, Gershlick A, Wegscheider K, Verhees L, Bonan R. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 2003;24:604-612.
23. Van Belle E, Ketelers R, Bauters C, Perie M, Abolmaali K, Richard F, Lablanche JM, McFadden EP, Bertrand ME. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: a key determinant of survival in diabetics after coronary balloon angioplasty. Circulation 2001;1031218-1224.
24. Van Belle E, Abolmaali K, Bauters C, McFadden EP, Lablanche JM, Bertrand ME. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. J Am Coll Cardiol 1999;34:476-485.
25. Kornowski R, Mintz GS, Kent KM, Pichard AD, Satler LF, Bucher TA, Hong MK, Popma JJ, Leon MB. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 1997;95:1366-1369.
26. Moreno PR, Fallon JT, Murcia AM, Leon MN, Simosa H, Fuster V, Palacios IF. Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients. J Am Coll Cardiol 1999;34:1045-1049.
27. Faries PL, Rohan DI, Takahara H, Wyers MC, Contreras MA, Quist WC, King GL, Logerfo FW. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg 2001;33:601-607.
28. Laskey W. Diabetics subset in START. Presented at the annual meeting of the American Heart Association. New Orleans; 2000.